BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22675457)

  • 1. Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.
    Inglés-Esteve J; Morales M; Dalmases A; Garcia-Carbonell R; Jené-Sanz A; López-Bigas N; Iglesias M; Ruiz-Herguido C; Rovira A; Rojo F; Albanell J; Gomis RR; Bigas A; Espinosa L
    PLoS One; 2012; 7(5):e38347. PubMed ID: 22675457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.
    Cho SG; Li D; Stafford LJ; Luo J; Rodriguez-Villanueva M; Wang Y; Liu M
    J Cell Biochem; 2009 Aug; 107(6):1139-49. PubMed ID: 19533666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.
    Byron SA; Min E; Thal TS; Hostetter G; Watanabe AT; Azorsa DO; Little TH; Tapia C; Kim S
    PLoS One; 2012; 7(10):e46823. PubMed ID: 23056468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
    Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
    Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPM1A is a RelA phosphatase with tumor suppressor-like activity.
    Lu X; An H; Jin R; Zou M; Guo Y; Su PF; Liu D; Shyr Y; Yarbrough WG
    Oncogene; 2014 May; 33(22):2918-27. PubMed ID: 23812431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral signaling protein MITA acts as a tumor suppressor in breast cancer by regulating NF-κB induced cell death.
    Bhatelia K; Singh A; Tomar D; Singh K; Sripada L; Chagtoo M; Prajapati P; Singh R; Godbole MM; Singh R
    Biochim Biophys Acta; 2014 Feb; 1842(2):144-53. PubMed ID: 24239807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.
    Moreira JM; Ohlsson G; Rank FE; Celis JE
    Mol Cell Proteomics; 2005 Apr; 4(4):555-69. PubMed ID: 15644556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
    Bennett L; Mallon EA; Horgan PG; Paul A; McMillan DC; Edwards J
    Oncotarget; 2017 May; 8(20):33002-33013. PubMed ID: 28423692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.
    Frasor J; Weaver A; Pradhan M; Dai Y; Miller LD; Lin CY; Stanculescu A
    Cancer Res; 2009 Dec; 69(23):8918-25. PubMed ID: 19920189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein.
    Raychaudhuri K; Chaudhary N; Gurjar M; D'Souza R; Limzerwala J; Maddika S; Dalal SN
    J Biol Chem; 2016 Jul; 291(31):16068-81. PubMed ID: 27261462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
    Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
    Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells.
    Ricca A; Biroccio A; Del Bufalo D; Mackay AR; Santoni A; Cippitelli M
    Int J Cancer; 2000 Apr; 86(2):188-96. PubMed ID: 10738245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation.
    Zheng G; Xiong Y; Yi S; Zhang W; Peng B; Zhang Q; He Z
    FEBS Lett; 2012 Jan; 586(2):163-8. PubMed ID: 22192357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
    J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
    Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
    Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.